Surface immobilized bisphosphonate improves stainless-steel screw fixation in rats

Biomaterials

Volumn 25, Issue 11, 2004, Pages 2133-2138

  Tengvall, P ^a   Skoglund, B ^a   Askendal, A ^a   Aspenberg, P ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Biomaterial; Bisphosphonate; Bone; Immobilize; Implant; Pullout

Indexed keywords

BONE; DRUG PRODUCTS; JOINT PROSTHESES; SCREWS; STAINLESS STEEL; SURGERY;

MECHANICAL FIXATION; PULLOUT STRENGTH;

BIOMATERIALS;

BISPHOSPHONIC ACID DERIVATIVE; FIBRINOGEN; IBANDRONIC ACID; PAMIDRONIC ACID; STAINLESS STEEL;

ADSORPTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BONE SCREW; CONTROLLED STUDY; CROSS LINKING; ENERGY; FORCE; IMMOBILIZATION; IMPLANTATION; MALE; MATERIAL COATING; NONHUMAN; OSTEOLYSIS; OSTEOSYNTHESIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RAT; STRENGTH; SURFACE PROPERTY; TIBIA;

EID: 0345868772     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2003.08.049     Document Type: Article

References (36)

1. Voggenreiter G., Leiting S., Brauer H., Leiting P., Majetschak M., Bardenheuer M.et al. Immuno-inflammatory tissue reaction to stainless-steel and titanium plates used for internal fixation of long bones. Biomaterials. 24(2):2003;247-254.
2. Larsson C., Esposito M., Liao H., Thomsen P. The titanium-bone interface in vivo. 2001;Springer, Berlin Heidelberg.
3. Kienapfel H., Sprey C., Wilke A., Griss P. Implant fixation by bone ingrowth. J Arthroplasty. 14(3):1999;355-368.
4. Christensen F.B., Dalstra M., Sejling F., Overgaard S., Bunger C. Titanium-alloy enhances bone-pedicle screw fixation. mechanical and histomorphometrical results of titanium-alloy versus stainless steel Eur Spine J. 9(2):2000;97-103.
5. Aspenberg P., Herbertsson P. Periprosthetic bone resorption. Particles versus movement. J Bone Jt Surg Br Vol. 78(4):1996;641-646.
6. Mjoberg B. The theory of early loosening of hip prostheses. Orthopedics. 20(12):1997;1169-1175.
7. Karrholm J., Borssen B., Lowenhielm G., Snorrason F. Does early micromotion of femoral stem prostheses matter? 4-7-year stereoradiographic follow-up of 84 cemented prostheses. J Bone Jt Surg Br Vol. 76(6):1994;912-917.
8. Qui S-J HS, Gibson G, Lundin-Cannon K, Schaffler M. In: Osteocyte apoptosis after acute matrix injury in compact bone. San Francisco: Transactions of the Orthopedic Research Society, 1997.
9. Bergstrom J.D., Bostedor R.G., Masarachia P.J., Reszka A.A., Rodan G. Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase. Arch Biochem Biophys. 373(1):2000;231-241.
10. Fisher J.E., Rogers M.J., Halasy J.M., Luckman S.P., Hughes D.E., Masarachia P.J.et al. Alendronate mechanism of action. geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro Proc Nat Acad Sci USA. 96(1):1999;133-138.
11. Meraw S.J., Reeve C.M., Wollan P.C. Use of alendronate in peri-implant defect regeneration. J Periodontol. 70(2):1999;151-158.
12. Meraw S.J., Reeve C.M. Qualitative analysis of peripheral peri-implant bone and influence of alendronate sodium on early bone regeneration. J Periodontol. 70(10):1999;1228-1233.
13. Yoshinari M., Oda Y., Inoue T., Matsuzaka K., Shimono M. Bone response to calcium phosphate-coated and bisphosphonate-immobilized titanium implants. Biomaterials. 23(14):2002;2879-2885.
14. McCrackin FL. A FORTRAN program for the analysis of ellipsometer measurements. NBS Technical Note 479, Washington, DC, 1969.
15. de Feijter J.A., Benjamins J., Veer F.A. Ellipsometry as a tool to study the adsorption of synthetic and biopolymers at the air-water interface. Biopolymers. 17:1978;1759-1773.
16. Benesch J., Askendal A., Tengvall T. Quantification of adsorbed human serum albumin at solid interfaces. a comparison between radioimmunoassay (RIA) and simple null ellipsometry Colloids Surf B: Biointerfaces. 2000;71-81.
17. Stenberg M., Nygren H. The use of the isoscope ellipsometer in the study of adsorbed proteins and biospecific binding reactions. J Phys. C10(Suppl.12):1983;83-86.
18. Skripitz R., Aspenberg P. Implant fixation enhanced by intermittent treatment with parathyroid hormone. J Bone Jt Surg Br Vol. 83(3):2001;437-440.
19. Tengvall P., Jansson E., Askendal A., Thomsen P., Gretzer C. Preparation of multilayer plasma protein films by EDS/NHS coupling chemistry on silicon. Colloids Surf B: Biointerfaces. 28(4):2003;261-272.
20. Hermanson G.T., Mallia A.K., Smith P.K. Immobilized affinity ligand techniques. 1992;Academic Press Inc. San Diego.
21. Rejda B.V., Peelen J.G., Vermeiden J.H., de Groot K. Bone substitute made from calcium phosphate. Ned Tijdschr Geneesk. 122(18):1978;625-628.
22. de Groot K., Wolke J.G., Jansen J.A. Calcium phosphate coatings for medical implants. Proc Inst Mech Eng [H]. 212(2):1998;137-147.
23. Paschalis E.P., Zhao Q., Tucker B.E., Mukhopadhayay S., Bearcroft J.A., Beals N.B.et al. Degradation potential of plasma-sprayed hydroxyapatite-coated titanium implants. J Biomed Mater Res. 29(12):1995;1499-1505.
24. Gross K.A., Ray N., Rokkum M. The contribution of coating microstructure to degradation and particle release in hydroxyapatite coated prostheses. J Biomed Mater Res. 63(2):2002;106-114.
25. Tong W., Chen J., Li X., Cao Y., Yang Z., Feng J.et al. Effect of particle size on molten states of starting powder and degradation of the relevant plasma-sprayed hydroxyapatite coatings. Biomaterials. 17(15):1996;1507-1513.
26. Piotrowski G., Hench L.L., Allen W.C., Miller G.J. Mechanical studies of the bone bioglass interfacial bond. J Biomed Mater Res. 9(4):1975;47-61.
27. Oonishi H., Hench L.L., Wilson J., Sugihara F., Tsuji E., Matsuura M.et al. Quantitative comparison of bone growth behavior in granules of Bioglass, A-W glass-ceramic, and hydroxyapatite. J Biomed Mater Res. 51(1):2000;37-46.
28. Ferris D.M., Moodie G.D., Dimond P.M., Gioranni C.W., Ehrlich M.G., Valentini R.F. RGD-coated titanium implants stimulate increased bone formation in vivo. Biomaterials. 20(23-24):1999;2323-2331.
29. Kantlehner M., Schaffner P., Finsinger D., Meyer J., Jonczyk A., Diefenbach B.et al. Surface coating with cyclic RGD peptides stimulates osteoblast adhesion and proliferation as well as bone formation. Chembiochem. 1(2):2000;107-114.
30. Schliephake H., Scharnweber D., Dard M., Rossler S., Sewing A., Meyer J.et al. Effect of RGD peptide coating of titanium implants on periimplant bone formation in the alveolar crest An experimental pilot study in dogs. Clin Oral Implants Res. 13(3):2002;312-319.
31. Schwartz Z., Kieswetter K., Dean D.D., Boyan B.D. Underlying mechanisms at the bone-surface interface during regeneration. J Periodontal Res. 32(1 Pt 2):1997;166-171.
32. Cochran D.L., Buser D., ten Bruggenkate C.M., Weingart D., Taylor T.M., Bernard J.P.et al. The use of reduced healing times on ITI implants with a sandblasted and acid-etched (SLA) surface. early results from clinical trials on ITI SLA implants Clin Oral Implants Res. 13(2):2002;144-153.
33. Eggli P.S., Muller W., Schenk R.K. Porous hydroxyapatite and tricalcium phosphate cylinders with two different pore size ranges implanted in the cancellous bone of rabbits. A comparative histomorphometric and histologic study of bony ingrowth and implant substitution. Clin Orthop Relat Res. 232:1988;127-138.
34. Bobyn J.D., Pilliar R.M., Cameron H.U., Weatherly G.C. The optimum pore size for the fixation of porous-surfaced metal implants by the ingrowth of bone. Clin Orthop Relat Res. 150:1980;263-270.
35. Skoglund B, Holmertz J, Aspenberg P. Systemic and local ibandronate enhances screw fixation, submitted for publication.
36. Frith J.C., Monkkonen J., Auriola S., Monkkonen H., Rogers M.J. The molecular mechanism of action of the antiresorptive and antiinflammatory drug clodronate. evidence for the formation in vivo of a metabolite that inhibits bone resorption and causes osteoclast and macrophage apoptosis Arthritis Rheum. 44(9):2001;2201-2210.